Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Bonnotte

Showing results (151-160 of 224) with videos related to

Pageof 23
Sort By:
British Journal of Haematology|October 11, 2011
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patientsDelphine Gobert, James B Bussel, Charlotte Cunningham-Rundles, et al.
Medicine|February 23, 2013
Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literatureAdèle de Masson, Jean-David Bouaziz, Régis Peffault de Latour, et al.
Journal of Autoimmunity|November 20, 2016
B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopeniaSylvain Audia, Marzia Rossato, Malika Trad, et al.
Frontiers in Immunology|March 10, 2023
Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritisMaxime Samson, Coraline Genet, Marc Corbera-Bellalta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2015
Good syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complicationsMarion Malphettes, Laurence Gérard, Lionel Galicier, et al.
Rheumatology (Oxford, England)|November 10, 2023
Dysregulation of neutrophil oxidant production and interleukin-1-related cytokines in granulomatosis with polyangiitisJennifer Amsler, Judith Everts-Graber, Katherine R Martin, et al.
JAMA Network Open|November 28, 2022
Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With PolyangiitisXavier Puéchal, Michele Iudici, Elodie Perrodeau, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 12, 2026
In synergy with interferon-gamma, interleukin-17 activates vascular stromal cells towards a pro-inflammatory profile in giant cell arteritisHélène Greigert, André Ramon, Claudie Cladiere, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 9, 2021
COVID-19 or not COVID-19? Compared characteristics of patients hospitalized for suspected COVID-19Thomas Rogier, Isabelle Eberl, Florian Moretto, et al.
Journal of Autoimmunity|May 17, 2021
Mucosal-associated invariant T cells in Giant Cell ArteritisThibault Ghesquière, Marion Ciudad, André Ramon, et al.
Pageof 23

Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
British Journal of Haematology|October 11, 2011
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patientsDelphine Gobert, James B Bussel, Charlotte Cunningham-Rundles, et al.
Medicine|February 23, 2013
Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literatureAdèle de Masson, Jean-David Bouaziz, Régis Peffault de Latour, et al.
Journal of Autoimmunity|November 20, 2016
B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopeniaSylvain Audia, Marzia Rossato, Malika Trad, et al.
Frontiers in Immunology|March 10, 2023
Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritisMaxime Samson, Coraline Genet, Marc Corbera-Bellalta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2015
Good syndrome: an adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complicationsMarion Malphettes, Laurence Gérard, Lionel Galicier, et al.
Rheumatology (Oxford, England)|November 10, 2023
Dysregulation of neutrophil oxidant production and interleukin-1-related cytokines in granulomatosis with polyangiitisJennifer Amsler, Judith Everts-Graber, Katherine R Martin, et al.
JAMA Network Open|November 28, 2022
Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With PolyangiitisXavier Puéchal, Michele Iudici, Elodie Perrodeau, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 12, 2026
In synergy with interferon-gamma, interleukin-17 activates vascular stromal cells towards a pro-inflammatory profile in giant cell arteritisHélène Greigert, André Ramon, Claudie Cladiere, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 9, 2021
COVID-19 or not COVID-19? Compared characteristics of patients hospitalized for suspected COVID-19Thomas Rogier, Isabelle Eberl, Florian Moretto, et al.
Journal of Autoimmunity|May 17, 2021
Mucosal-associated invariant T cells in Giant Cell ArteritisThibault Ghesquière, Marion Ciudad, André Ramon, et al.
Pageof 23